BindingDB logo
myBDB logout

BDBM50265539 4-hydroxy-3-(1-methyl-1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one::CHEMBL496172

SMILES: Cn1c(nc2ccccc12)-c1c(O)c2ccccc2[nH]c1=O

InChI Key: InChIKey=VUWFDMHOFQDZTG-UHFFFAOYSA-N

Data: 3 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50265539   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Vascular endothelial growth factor receptor 2


(Homo sapiens (Human))
BDBM50265539
PNG
(4-hydroxy-3-(1-methyl-1H-benzo[d]imidazol-2-yl)qui...)
Show SMILES Cn1c(nc2ccccc12)-c1c(O)c2ccccc2[nH]c1=O |(24.88,1.17,;24.55,2.67,;23.14,3.29,;23.3,4.82,;24.81,5.15,;25.56,6.48,;27.09,6.49,;27.87,5.16,;27.11,3.82,;25.57,3.82,;21.82,2.52,;20.47,3.3,;20.46,4.84,;19.13,2.51,;17.8,3.28,;16.47,2.5,;16.47,.96,;17.8,.19,;19.14,.96,;20.48,.19,;21.83,.97,;23.16,.2,)|
Show InChI InChI=1S/C17H13N3O2/c1-20-13-9-5-4-8-12(13)18-16(20)14-15(21)10-6-2-3-7-11(10)19-17(14)22/h2-9H,1H3,(H2,19,21,22)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a>2.50E+4n/an/an/an/an/an/a



Novartis Institutes for Biomedical Research

Curated by ChEMBL


Assay Description
Inhibition of human recombinant VEGFR2


J Med Chem 52: 278-92 (2009)


Article DOI: 10.1021/jm800790t
BindingDB Entry DOI: 10.7270/Q2TD9X7X
More data for this
Ligand-Target Pair
Platelet-derived growth factor receptor beta


(Homo sapiens (Human))
BDBM50265539
PNG
(4-hydroxy-3-(1-methyl-1H-benzo[d]imidazol-2-yl)qui...)
Show SMILES Cn1c(nc2ccccc12)-c1c(O)c2ccccc2[nH]c1=O |(24.88,1.17,;24.55,2.67,;23.14,3.29,;23.3,4.82,;24.81,5.15,;25.56,6.48,;27.09,6.49,;27.87,5.16,;27.11,3.82,;25.57,3.82,;21.82,2.52,;20.47,3.3,;20.46,4.84,;19.13,2.51,;17.8,3.28,;16.47,2.5,;16.47,.96,;17.8,.19,;19.14,.96,;20.48,.19,;21.83,.97,;23.16,.2,)|
Show InChI InChI=1S/C17H13N3O2/c1-20-13-9-5-4-8-12(13)18-16(20)14-15(21)10-6-2-3-7-11(10)19-17(14)22/h2-9H,1H3,(H2,19,21,22)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 1.10E+3n/an/an/an/an/an/a



Novartis Institutes for Biomedical Research

Curated by ChEMBL


Assay Description
Inhibition of human recombinant PDGFRbeta


J Med Chem 52: 278-92 (2009)


Article DOI: 10.1021/jm800790t
BindingDB Entry DOI: 10.7270/Q2TD9X7X
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 1


(Homo sapiens (Human))
BDBM50265539
PNG
(4-hydroxy-3-(1-methyl-1H-benzo[d]imidazol-2-yl)qui...)
Show SMILES Cn1c(nc2ccccc12)-c1c(O)c2ccccc2[nH]c1=O |(24.88,1.17,;24.55,2.67,;23.14,3.29,;23.3,4.82,;24.81,5.15,;25.56,6.48,;27.09,6.49,;27.87,5.16,;27.11,3.82,;25.57,3.82,;21.82,2.52,;20.47,3.3,;20.46,4.84,;19.13,2.51,;17.8,3.28,;16.47,2.5,;16.47,.96,;17.8,.19,;19.14,.96,;20.48,.19,;21.83,.97,;23.16,.2,)|
Show InChI InChI=1S/C17H13N3O2/c1-20-13-9-5-4-8-12(13)18-16(20)14-15(21)10-6-2-3-7-11(10)19-17(14)22/h2-9H,1H3,(H2,19,21,22)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 7.90E+3n/an/an/an/an/an/a



Novartis Institutes for Biomedical Research

Curated by ChEMBL


Assay Description
Inhibition of human recombinant FGFR1


J Med Chem 52: 278-92 (2009)


Article DOI: 10.1021/jm800790t
BindingDB Entry DOI: 10.7270/Q2TD9X7X
More data for this
Ligand-Target Pair